|Articles|May 15, 2002

BioPharm International

  • BioPharm International-05-01-2002
  • Volume 15
  • Issue 5

The Not-So-Sure Thing

by Benjamin H. Rudolph, Aptgen, Inc. What's an investor to do when previously rock-solid investments suddenly aren't?
To view a PDF of this article from the BioPharm International archives, click this link

Articles in this issue

over 23 years ago

Info+

over 23 years ago

Analytical Advances: Strategies in Clarifying Mammalian Cultures

over 23 years ago

Analytical Advances: Using Image Informatics - Focusing Proteomics

over 23 years ago

Washington Report: Vaccine Shortages put Spotlight on Production

over 23 years ago

Outsourcing Outlook: E-Procurement ? Successfully Using and Managing Reverse Auctions

over 23 years ago

Guest Editorial: Validation Bingo

over 23 years ago

Travel Notes: Yes, Virginia, There is Biotech in the Commonwealth

over 23 years ago

Development of an In Situ Spectroscopic Method for Cleaning Validation using Mid-IR Fiber-Optics

over 23 years ago

Validation of Large-Scale Chromatographic Processes, Part 1: Case Study of Neuleze Capture on Macroprep High-S

over 23 years ago

Freezing Bulk-Scale Biopharmaceuticals Using Common Techniques ? and the Magnitude of Freeze-Concentration

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!